Zhenhua Zhou

Papers

Total Citations

H-Index

About

Dr. Zhenhua Zhou is a pioneering researcher in precision nanomedicine and thrombolytic therapy, with a focus on developing intelligent, feedback-regulated drug delivery systems to address critical challenges in cardiovascular treatment. His landmark 2025 study, "Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk," has garnered 6 citations and represents a paradigm shift in managing thrombolysis resistance. By uncovering the relationship between thrombus heterogeneity and treatment outcomes, Dr. Zhou engineered a biomarker-responsive platform that dynamically adjusts drug release based on real-time physiological cues, significantly reducing the hemorrhagic risks associated with conventional body weight-based dosing strategies. This work directly tackles the clinical defects in recanalization rates and post-thrombolysis hemorrhage that plague current protocols. His contributions bridge the gap between materials science and clinical medicine, offering a personalized, safer alternative for stroke and thrombosis patients. Dr. Zhou’s research holds transformative potential for precision thrombolysis, positioning him as a rising leader in the field of smart therapeutics and bioinspired nanomedicine.